Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study (Q46222744)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study |
scientific article |
Statements
1 reference
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study (English)
1 reference
Martin Bohus
1 reference
Mary C Zanarini
1 reference
S Charles Schulz
1 reference
Anthony Bateman
1 reference
Holland C Detke
1 reference
Quynh Trzaskoma
1 reference
Yoko Tanaka
1 reference
Daniel Lin
1 reference
Walter Deberdt
1 reference
Sara Corya
1 reference
1 December 2008
1 reference
193
1 reference
6
1 reference
485-492
1 reference